The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-14.4% to $17.50
Predicted High$22.80at 2 months
Predicted Low$17.50at 6 months
Max Drawdown (predicted)-14.4%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 19, 2026 12:21 pm
Bear
PGY trends lower to
$17.50
(-14.4% from $20.45)
by Feb 2027.
ride-then-fade
ThesisPGY is a high-beta, narrative-driven AI-credit name riding a risk-on tape with strong sentiment and 4-of-4 earnings beats, but stretched valuation (attractive only below $15.50) and negative value/quality scores create fade risk if regime cools. Expect near-term momentum continuation into a likely Q3 print, then mean-reversion pressure as the 65% trailing rally digests.
Invalidated ifA regime flip to risk-off, break below $17 on volume, or an earnings miss would invalidate the momentum leg; sustained close above $24 would invalidate the fade leg.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $20.45 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 19, 2026
—
$20.45at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 2, 2026
$17.49–$23.41typical range · internal point $21.30
—
±14.5%
6/10
Risk-on regime and momentum extend near-term drift higher
What actually happened:
closed $20.94
on Sep 1, 2026 = +2.4% vs the call
(predicted +4.2%)
· direction HIT
(called flat, was flat)
· off by 1.8 pp
· accuracy 10/10
· typical range ±14.5%:
inside the band
· S&P -1.0%
over the same window — beat it
1 month
Sep 19, 2026
$16.16–$24.74typical range · internal point $22.10
—
±21.0%
5/10
Sentiment tailwind and high beta amplify tape gains
Year-end profit-taking on 65% YTD run; beta cuts both ways
5 months
Jan 19, 2027
$18.20
—
-11.0%
3/10
Value lens weight increases as narrative premium compresses
6 months
Feb 19, 2027
$17.50
—
-14.4%
3/10
Drift toward attractive-below-$15.50 zone absent new catalyst
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.